Recently, Thermo Fisher Scientific signed a cooperation agreement with Guangzhou Economic and Technological Development Zone Administrative Commission, announcing that Thermo Fisher Scientific Guangdong-Hong Kong-Macao Greater Bay Area base will be established in the Guangzhou Development Zone. The base is scheduled to be ready for production in 2023 with clean plants, production processes and facilities.

Thermo Fisher Scientific

Guangdong-Hong Kong-Macao Greater Bay Area base

The planned new site in Guangdong-Hong Kong-Macao Greater Bay Area is located in the International Biomedical Innovation Center of the Sino-Singapore Guangzhou Knowledge City, covering an area of approximately 16,000 square meters and is planned to include life science, biopharmaceutical, reagent, R&D and manufacturing centre and scientific instrument manufacturing. The completed base will leverage Thermo Fisher Scientific's cutting-edge technology to produce high value-added products including high-end laboratory equipment, analytical instruments and laboratory consumables.

Hann Pang, President of Thermo Fisher Scientific China

“The Guangdong-Hong Kong-Macao Greater Bay Area is an important region for China's biopharmaceutical industry, and is one of the key regions in the "14th Five-Year Plan" for the development of a bio-economic pioneer zone. Thanks to the Guangzhou Municipal Government's efforts to promote the biopharmaceutical industry in a multi-dimensional and comprehensive manner, the GZDZ has become a highland for the development of biopharmaceutical industries with global competitiveness and influence. Thermo Fisher's investment in the Guangdong, Hong Kong, Macau and Bay Area base will further expand Thermo Fisher's local development strategy of "Rooted in China, Serving China" and will continue to empower the regional industrial ecology.”